Whitehawk Therapeutics, Inc. (WHWK) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts WHWK Hot Sheet
Join SI Premium – FREE
Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q2 EPS of ($0.20), $0.11 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dell shares surge on record AI server bookings
- SEALSQ posts 131% revenue gain in H1 2026, net loss widens
- Active options: SPCX MU GME AMD GOOG MSFT HOOD CRWV IREN ADBE AVGO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
